Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Pharmacogenetics and Genomics|July 25, 2023
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2 , and CYP2C9 variantsK Ivar Lönnberg, Aleksi Tornio, Päivi Hirvensalo, et al.British Journal of Clinical Pharmacology|February 6, 2023
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein-mediated drug interaction?Minna Lehtisalo, Wilma Kiander, Anne M Filppula, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 3, 2019
Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8Helinä Kahma, Anne M Filppula, Terhi Launiainen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2021
Comparative Hepatic and Intestinal Efflux Transport of StatinsFeng Deng, Suvi-Kukka Tuomi, Mikko Neuvonen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 28, 2021
Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of StatinsAnne M Filppula, Päivi Hirvensalo, Heli Parviainen, et al.Smart Medicine|March 10, 2025
Biomineralize Mitochondria in Metal-Organic Frameworks to Promote Mitochondria Transplantation From Non-Tumorigenic Cells Into Cancer CellsJun-Nian Zhou, Chang Liu, Yonghui Wang, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 2024
Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in HumansMikael O W Piha, Kristiina Cajanus, Marica T Engström, et al.Clinical Pharmacology and Therapeutics|October 3, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate RosuvastatinMinna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 23, 2021
An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes - application to establishing CYP2C8 inhibitor selectivityHelinä Kahma, Laura Aurinsalo, Mikko Neuvonen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2017
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug InteractionsHelinä Kahma, Anne M Filppula, Mikko Neuvonen, et al.Pageof 4